A substantial part of the NIH portfolio, appropriately, focuses on basic science. Basic science meaning fundamental biological facts that can be used in many many drug studies, other research where you don’t necessarily know specifically in advance when you’re doing it what the application’s going to be. The NIH, very appropriately, funds that work, especially work that’s not patentable, because no drug company has an incentive to do that work, and yet it’s vital.
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
2 Responses
The two Stanford docs do not restore my trust when they try to rationalize the obscene profits of big pharma with a 30 year old canard, that the high cost of the large scale safety and efficacy studies they are required to conduct raises the ultimate price of the drugs. Those studies are a cost of doing business and are deducted from gross income. The net income after that is still obscene and results from unregulated price gouging.
Don’t trust either of these doctors. Heard them both repeating the propaganda that the C-vac saved lives.